Gluco6 Side Effects: Safety Points to Check

A named list is worth most on a safety page. Six names can be read against an allergy, a medicine cabinet and a personal rule about stimulants, and three of the six carry specific, documented cautions that are worth knowing before the first capsule rather than after.

Green tea extract and the liver

This is the largest safety file attached to any of the six, and it is not a marginal one. LiverTox, maintained by NIDDK, scores green tea extract A: a well established cause of clinically apparent liver injury, with more than 100 published cases, some ending in acute liver failure, transplant or death. Brewed green tea as a drink is not implicated; concentrated extract is.

The injury is idiosyncratic rather than dose-dependent — so there is no safe threshold to quote. What the literature does give is a range: the US Pharmacopeia review reports cases at EGCG intakes from about 140 mg a day upward. The Gluco6 label names green tea and gives no EGCG figure, so a reader cannot locate this capsule on that range.

The same USP review found that taking green tea extract on an empty stomach significantly increases catechin absorption, which is why its monograph requires the label caution “do not take on an empty stomach, take with food”. The Gluco6 direction is one capsule in the morning before breakfast. Those two instructions point in opposite directions, and a reader who would rather follow the pharmacopeia than the sales page can take the capsule with a meal instead.

Chromium, and what no upper limit means

NIH’s Office of Dietary Supplements is explicit that the Food and Nutrition Board has not set a Tolerable Upper Intake Level for chromium, while noting that the data are limited and that caution may be warranted, particularly for people with kidney or liver disease. No upper limit has been set is not the same sentence as no amount can be too much, and the fact sheet itself lists isolated case reports of liver dysfunction, renal failure, rhabdomyolysis and low blood sugar.

It also carries an interaction most readers will not expect: chromium can reduce the absorption of levothyroxine, so the two are usually separated by several hours. If you take thyroid medication in the morning, that timing question is worth raising before you add a morning capsule.

Cinnamon, species and coumarin

NCCIH makes two points that apply directly to this label. Cinnamon products often fail to identify the species or the plant part; and cassia cinnamon contains coumarin, which in prolonged high intake could be a problem for people with liver disease. The bottle prints “Cinnamon” on its own, so neither question can be answered from the front of the pack.

The two remaining names are quieter. Gymnema’s issue is an interaction rather than a toxicity and it has a section of its own below. Sukre’s published safety record is a 28-day study in rats, which found no adverse effects at up to 7,200 mg/kg a day and was paid for by the company that owns the name; there is no human safety data on it at all.

Named precisely, this is who it applies to: anyone taking insulin, a sulfonylurea such as glipizide or glimepiride, or a meglitinide such as repaglinide. NIDDK names those three classes as the drugs that cause low blood glucose, because they lower it whether or not the body needs them to.

The mechanism of the problem is addition — not interference. A prescription for diabetes lowers blood glucose deliberately and to a target somebody chose, and several of the plants and the mineral on this panel have been studied doing a weaker, less predictable version of the same thing. NIH’s Office of Dietary Supplements states it directly for chromium: it might have an additive effect with metformin or other antidiabetes medications and thus might increase the risk of hypoglycemia, and taken with insulin it could increase that risk. Because the blend is undivided, the size of that addition cannot be estimated by anyone, including this desk.

The numbers to know are short. Act at 70 mg/dL or below if you have diabetes; MedlinePlus puts the threshold at 55 mg/dL for someone who does not. Severely low blood glucose is defined by needing someone else’s help rather than by a reading, and it can cause unconsciousness, coma or death.

The symptoms are worth reading once before they matter: shakiness, sweating, a fast heartbeat, confusion, irritability, sudden hunger, dizziness or blurred vision. In somebody who takes one of the three drug classes above, that combination is treated as low blood sugar until a meter says otherwise.

So the conversation to have is with whoever set your dose, before the first capsule, and it is about that dose rather than about whether supplements are worthwhile. If you start it anyway, the fortnight after the first capsule is when you test as usual and write the readings down. Who this is for covers the rest of the groups the audience statement excludes.